يعرض 1,941 - 1,960 نتائج من 4,785 نتيجة بحث عن 'significantly ((observed decrease) OR (teer decrease))', وقت الاستعلام: 0.25s تنقيح النتائج
  1. 1941

    Schematic of the test equipment. حسب Decang Lou (21439960)

    منشور في 2025
    "…However, when the simulated surface temperature of the vane was compared with the cooling test data, in which the vane was 3D-printed, significant deviation of the surface temperature distribution was observed. …"
  2. 1942

    Schematic model depicting the relationship between lipids and proteins by target gene knockdown. حسب Takuya Kitamoto (11721639)

    منشور في 2025
    "…Non-significant but decreasing trends are marked with small light blue arrows pointing downwards. …"
  3. 1943
  4. 1944

    Technical properties of tested UASs. حسب Marc Roswag (20598443)

    منشور في 2025
    "…Additionally, we hypothesized that (iii) any initial deterrence or attraction effect might decrease over time. Our results did not support this hypothesis because we did not observe any habituation of bats to UAS within the 15-minute flight period. …"
  5. 1945
  6. 1946
  7. 1947

    Stacked bar chart illustrates the distribution of NMIBC, MIBC across age groups for males and females. حسب Yi Hong Li (21485068)

    منشور في 2025
    "…In age groups below 70, females demonstrated a comparable or slightly higher percentage of NMIBC compared to males, whereas in age groups above 70, the percentage of NMIBC was significantly lower in females. Conversely, the percentage of MIBC showed an opposite pattern, with higher proportions observed in females in the older age groups.…"
  8. 1948

    Basic characteristics of participants. حسب Sebastian Bańkowski (10515614)

    منشور في 2025
    "…However, BDNF levels increased by 21% in the CUR group post-supplementation, while a 5% decrease was observed in the PLA group. These findings do not support a significant effect of curcumin supplementation on inflammatory markers, blood count, or BDNF concentration. …"
  9. 1949

    Participants flow chart. حسب Sebastian Bańkowski (10515614)

    منشور في 2025
    "…However, BDNF levels increased by 21% in the CUR group post-supplementation, while a 5% decrease was observed in the PLA group. These findings do not support a significant effect of curcumin supplementation on inflammatory markers, blood count, or BDNF concentration. …"
  10. 1950

    S1 Data - حسب Sebastian Bańkowski (10515614)

    منشور في 2025
    "…However, BDNF levels increased by 21% in the CUR group post-supplementation, while a 5% decrease was observed in the PLA group. These findings do not support a significant effect of curcumin supplementation on inflammatory markers, blood count, or BDNF concentration. …"
  11. 1951

    Source data for Fig 2. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  12. 1952

    Cataract induction does not affect hunting behaviour in optimal light conditions (left panels) but causes impairments in challenging light environments (right panels). حسب Amartya T. Mitra (14043115)

    منشور في 2025
    "…Similarly, under bright and UV light, we did not detect differences in hunting success (E,G; <i>n</i><sub><i>control</i></sub> = 12, <i>n</i><sub><i>lens3RNAi </i></sub>= 23, <i>p</i><sub>horizontal</sub> = 0.28, <i>p</i><sub>vertical</sub> = 0.23), but observed a weak (nonsignificant) decrease in the hunting success of treatment individuals under dim white light (F,H; <i>n</i><sub><i>control</i></sub> = 13, <i>n</i><sub><i>lens3RNAi </i></sub>= 22, <i>p</i><sub>horizontal</sub> = 0.22, <i>p</i><sub>vertical</sub> = 0.42).…"
  13. 1953

    Source data for lung metabolomics. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  14. 1954

    Source data for Fig 5. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  15. 1955

    Source data for Fig 1. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  16. 1956

    Flow cytometry gating strategy for MDSC. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  17. 1957

    Source data for Fig 3. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  18. 1958

    Source data for Fig 4. حسب Qi Xu (134661)

    منشور في 2025
    "…Importantly, when we knocked out the <i>Ido1</i> gene or inhibited IDO1 expression using a specific inhibitor 1-MT in mice, we observed a significant enhancement in T-cell mediated responses against hv<i>Kp</i>. …"
  19. 1959

    Data extraction information. حسب Siyuan Chen (200219)

    منشور في 2025
    "…Meta-analysis suggested a significant superiority of biologic agents in prolonging relapse-free survival, increasing glucocorticoid taper rate, and decreasing cumulative glucocorticoids dose for both GCA and TAK. …"
  20. 1960

    ROB 2.0 for RCT. حسب Siyuan Chen (200219)

    منشور في 2025
    "…Meta-analysis suggested a significant superiority of biologic agents in prolonging relapse-free survival, increasing glucocorticoid taper rate, and decreasing cumulative glucocorticoids dose for both GCA and TAK. …"